# Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

> **NCT00790452** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00790452
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low accrual.
- **Last updated:** 2011-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790452, "Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00790452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*